In this article we report a novel Ag NPs fabricated
chitosan-
agarose composite functionalized core-shell type Fe3O4 nanoparticle (Ag/CS-
Agar@Fe3O4). The biogenic material was analyzed over a number of physicochemical methods like, FT-IR, FE-SEM, TEM, EDX, XRD, VSM and ICP-OES. In catalytic exploration we aimed the synthesis of diverse 2H-indazolo0-b]
phthalazine-trione derivatives via one-pot three component coupling of phathalalhydrazide,
dimedone and different
aldehydes. It afforded good to excellent yields under
solvent-less conditions. Robustness of the catalyst was justified by catalyst recyclability for consecutive 10 times, hot filtration and leaching tests. Again,
biological activity of the material was evaluated by studying the
antioxidant and cytotoxicity properties over lung and
liver cancer cell lines.
Antioxidant potential of Ag/CS-
Agar@Fe3O4 was assessed by DPPH radical scavenging studies and the corresponding IC50 was found to be 96.57 μg/mL. Liver and
lung cancer studies over Ag/CS-
Agar@Fe3O4 was carried out by MTT assay against HepG2 and A549 cell lines. The corresponding IC50 values were found as 192.35 and 365.28 μg/mL respectively. % Cell viability of the nanomaterial decreased dose dependently over both the cell lines without any cytotoxicity on normal cell line. The results demonstrates Ag/CS-
Agar@Fe3O4 nanocomposite to be an efficient chemotherapeutic
drug against the lung and
hepatocellular carcinoma cells.